Sort
21,453 grants matching “tuberculosis”
NERBL Core 3: Biocontainment Research Support Services
$393,231Sam R. Telford · Tufts University Boston · UC7 · FY2025 · AI
Cell Wall Biogenesis-Target for new Anti-TB drugs
$393,224Michael R McNeil · Colorado State University · R01 · FY2006 · AI
ROLE OF CELL WALL INTEGRITY IN ECHINOCANDIN RESISTANCE IN C. NEOFORMANS
$393,125Jennifer K. Lodge · Washington University · R01 · FY2017 · AI
Deciphering of the Toxin-Antitoxin Systems in E. coli
$393,072Masayori Inouye · Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2010 · GM
Type I Interferons in Immunity to Tuberculosis
$392,994Joel D. Ernst · New York University School Of Medicine · R01 · FY2008 · AI
Targeting matrix metalloproteinases to limit immunopathology in airborne infectio
$392,886Paul Timothy Elkington · University Of Southampton · R33 · FY2014 · AI
DECISION TO TREAT--DENTAL PRACTICE AS RISK BEHAVIOR
$392,864Columbia University Health Sciences · R01 · FY2000 · DE
Mechanisms of Mycobacterial Antigen Processing
$392,842Chinnaswamy Jagannath · University Of Texas Hlth Sci Ctr Houston · R01 · FY2013 · AI
Mechanisms of Mycobacterium Tuberculosis pH-driven Adaptation
$392,824Robert B Abramovitch · Michigan State University · R01 · FY2016 · AI
ALASKA TUBERCULOSIS ELIMINATION AND LABORATORY
$392,758Michael Cooper · Alaska State Department Of Hlth-Soc Svcs · U52 · FY2013 · PS
Bacterial and Liposomal Antigen Processing
$392,500Clifford V Harding · Case Western Reserve University · R01 · FY2009 · AI
Folate Metabolism in Mycobacterium tuberculosis Revisited: A Potential Drug Targe
$392,500Liem Duy Nguyen · Case Western Reserve University · R01 · FY2010 · AI
Mechanisms of antibiotic resistance development in bacterial pathogens
$392,500Houra Merrikh · Vanderbilt University · R01 · FY2019 · AI
Mechanisms of antibiotic resistance development in bacterial pathogens
$392,500Houra Merrikh · Vanderbilt University · R01 · FY2021 · AI
SCREEN DEVELOPMENT FOR ANTIMICROBIAL PRODRUGS
$392,500Kim Lewis · Northeastern University · R01 · FY2007 · AI
Mechanisms of antibiotic resistance development in bacterial pathogens
$392,500Houra Merrikh · Vanderbilt University · R01 · FY2020 · AI
Bacterial and Liposomal Antigen Processing
$392,500Clifford V Harding · Case Western Reserve University · R01 · FY2008 · AI
PHARMACOKINETICS AND TOXICITY OF 2ND LINE ANTI-TB DRUGS IN HIV-INFECTED CHILDREN
$392,469Anneke Catharina Hesseling · Stellenbosch University · R01 · FY2015 · HD
Validating cholesterol-mediated Mycobacterium tuberculosis resistance to oxidative stress as a drug target
$392,421Nicole S. Sampson · State University New York Stony Brook · R01 · FY2018 · AI
The role of selenoprotein I in phospholipidethanolamine dependent mechanisms that regulate T cell activation
$392,251Peter R Hoffmann · University Of Hawaii At Manoa · R01 · FY2019 · AI
Systems Biology Core
$392,226William Evan Johnson · Rutgers Biomedical And Health Sciences · U19 · FY2024 · AI
The role of TIM-3 in regulating T cell function during tuberculosis
$392,221Samuel M Behar · Brigham And Women'S Hospital · P01 · FY2018 · AI
TB VACCINE DEVELOPMENT IN NONHUMAN PRIMATE MODEL
$392,091John L Vandeberg · Texas Biomedical Research Institute · P51 · FY2009 · RR
leDEA Networks Coordinating Center at Vanderbilt
$392,000Mary Lou Lindegren · Vanderbilt University · U01 · FY2014 · AI
SIV/MYCOBACTERIUM COINFECTION
$391,953Beth Israel Deaconess Medical Center · R01 · FY2000 · RR